(VIANEWS) – The NASDAQ ended the session with FibroGen (FGEN) jumping 4.16% to $11.51 on Thursday while NASDAQ Composite rose 1.73% to $14,823.43.
Today’s last reported volume for FibroGen is 970367, 36.45% below its average volume of 1527170.
FibroGen’s last close was $11.05, 80.69% under its 52-week high of $57.21.
FibroGen’s sales growth is 201.9% for the current quarter and 13.3% for the next. The company’s growth estimates for the ongoing quarter is a negative 134.3% and positive 39.1% for the next.
Year-on-year quarterly revenue growth declined by 43.2%, now sitting on 171.82M for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
FibroGen’s stock is considered to be oversold (<=20).
FibroGen’s Stock Yearly Top and Bottom Value
FibroGen’s stock is valued at $11.51 at 17:15 EST, way under its 52-week high of $57.21 and way higher than its 52-week low of $9.88.
FibroGen’s Moving Average
FibroGen’s worth is above its 50-day moving average of $11.17 and way under its 200-day moving average of $18.42.
More news about FibroGen (FGEN).